公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2018 | Antagonizing SET augments the effects of radiation therapy in hepatocellular carcinoma through reactivation of PP2A-Mediated akt downregulation | CHAO YUAN HUANG ; Hung M.-H.; Shih C.-T.; Hsieh F.-S.; Kuo C.-W.; Tsai M.-H.; Chang S.-S.; Hsiao Y.-J.; Chen L.-J.; Chao T.-I.; Chen K.-F. | Journal of Pharmacology and Experimental Therapeutics | 12 | 9 | |
2019 | Canagliflozin inhibits growth of hepatocellular carcinoma via blocking glucose-influx-induced β-catenin activation | Hung M.-H.; Chen Y.-L.; Chen L.-J.; Chu P.-Y.; Hsieh F.-S.; Tsai M.-H.; Shih C.-T.; Chao T.-I.; CHAO YUAN HUANG ; Chen K.-F. | Cell Death and Disease | 48 | ||
2018 | Palbociclib enhances radiosensitivity of hepatocellular carcinoma and cholangiocarcinoma via inhibiting ataxia telangiectasia-mutated kinase-mediated DNA damage response | CHAO YUAN HUANG ; Hsieh F.-S.; Wang C.-Y.; Chen L.-J.; Chang S.-S.; Tsai M.-H.; Hung M.-H.; Kuo C.-W.; Shih C.-T.; Chao T.-I.; Chen K.-F. | European Journal of Cancer | 49 | ||
2018 | Serine/threonine protein phosphatase 5 is a potential therapeutic target in cholangiocarcinoma | Hu M.-H.; Huang T.-T.; Chao T.-I.; Chen L.-J.; Chen Y.-L.; Tsai M.-H.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Liver International | 7 | 6 | |
2017 | Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma | Hu M.-H.; Chen L.-J.; Chen Y.-L.; Tsai M.-S.; Shiau C.-W.; Chao T.-I.; Liu C.-Y.; JIA-HORNG KAO ; Chen K.-F. | Oncotarget | 17 | 15 | |
2021 | TD-92, a novel erlotinib derivative, depletes tumor-associated macrophages in non-small cell lung cancer via down-regulation of CSF-1R and enhances the anti-tumor effects of anti-PD-1 | Shih C.-T.; Shiau C.-W.; Chen Y.-L.; Chen L.-J.; Chao T.-I.; Wang C.-Y.; CHAO YUAN HUANG ; Hung M.-H.; Chen K.-F. | Cancer Letters | 12 | 10 |